TSTickerStarGet alerts

DataMEDS AI Establishes Health Lives Here Community Respiratory Program for Corexa Health Pharmacy Network

DataMEDS AI announced the establishment of its Health Lives Here Community Respiratory Program, which will be marketed to the 6,500+ independent pharmacies in the Corexa Health Pharmacy Network. The program aims to bring respiratory season best practices to community pharmacies and improve access to protein-based vaccines, diagnostics, and therapeutics. The program will first launch at Corexa Pharmacy in Lakeland, Florida in Q4 2026, with potential revenue streams from vaccine and antiviral dispensing, rapid tes...

Share this story

Key takeaways

  • Health Lives Here Community Respiratory Program launched to target 6,500+ independent pharmacies in Corexa Health Pharmacy Network

  • Program to launch first at Corexa Pharmacy in Lakeland, Florida in Q4 2026

  • Nuvaxovid protein-based non-mRNA COVID-19 vaccine prioritized for vaccination campaign

  • Program includes COVID-19 and influenza rapid point-of-care testing, COVID neutralizing antibody testing, and Long COVID biomarker panels

  • Telehealth services to be available through Health Lives Here mobile application for evaluation and antiviral prescriptions

  • Program aims to improve access to FDA-approved antivirals and Tollo Health medical foods including Galectovid

  • U.S. vaccines market estimated at $26 billion in 2025, projected to reach $40 billion by 2033 per Grand View Research

Key metrics

Target pharmacy network sizeannouncement date
6,500+ independent pharmacies
U.S. vaccines market size 20252025
$26 billion
U.S. vaccines market projection 20332033
$40 billion
U.S. viral respiratory treatment market 20242024
$16.63 billion
U.S. viral respiratory treatment market projection 20322032
$35.33 billion
U.S. respiratory diagnostics market 20252025
$4.5 billion
U.S. respiratory diagnostics market projection 20332033
$5.7 billion

Primary source

TickerStar generated this brief from an official company, investor-relations, earnings-call, or regulatory source. Review the primary material before making an investment decision.

Open Investor relations

Follow MEDS in real time

Get material earnings, filing, IR, and earnings-call alerts by email.

Create a free alert